EU-IPFF Financial Statement June 2020 to May 2021
18-03-2022
For the Fiscal year 2020 (June 2020 to May 2021), the EU-IPFF received a total of 673.352,30€ as operating income (please read and download the audited accounting report as provided to the Belgian authorities below).
The graph shows the distribution of the overall funding received by the Federation by type of funding and an overview of the percentage provided by each of the pharmaceutical companies (68% of the overall income). Boehringer Ingelheim was the pharmaceutical company that provided a relatively high amount of funding to the EU-IPFF activities, 31.1% of the overall income.
